BioNTech Vaccine Treats MS in Mice Without Dampening Immune System

BioNTech Vaccine Treats MS in Mice Without Dampening Immune System

282390

BioNTech Vaccine Treats MS in Mice Without Dampening Immune System

BioNTech’s experimental non-inflammatory vaccine — designed to dampen the abnormal immune responses seen in multiple sclerosis (MS) against myelin — delayed the onset and lessened the severity of symptoms in a mouse model of MS, a study reports. Importantly, treated mice showed no signs of overall immune suppression, suggesting that this type of therapy may overcome the downsides associated with current immunosuppressive therapies for MS. These data support advancing this vaccine, and possibly bringing it into…

You must be logged in to read/download the full post.